💰 Kamada Updates on Withholding Tax Procedures
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
REHOVOT, Israel and HOBOKEN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the 'Company”) (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced today that it has obtained a tax ruling (the 'Ruling”) from the Israel Tax Authority (the 'ITA”) with respect to the cash dividend of $0.17 (approximately NIS 0.51) per share on the Company’s ordinary shares (totaling approximately $9.8 million) announced on August 17, 2026 (the 'Dividend”), e
Key points
- REHOVOT, Israel and HOBOKEN, N.
- 03, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
- (the 'Company”) (NASDAQ: KMDA; TASE: KMDA.
- TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced today that it has obtained a tax ruling (the 'Ruling”) from the Israel Tax Authority (the 'ITA”) with respect to the cash dividend of $0.
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #business
- #kamada
- #updates